ZA200701311B - A purified arabinogalactan-protein (AGP) composition - Google Patents

A purified arabinogalactan-protein (AGP) composition

Info

Publication number
ZA200701311B
ZA200701311B ZA200701311A ZA200701311A ZA200701311B ZA 200701311 B ZA200701311 B ZA 200701311B ZA 200701311 A ZA200701311 A ZA 200701311A ZA 200701311 A ZA200701311 A ZA 200701311A ZA 200701311 B ZA200701311 B ZA 200701311B
Authority
ZA
South Africa
Prior art keywords
agp
protein
composition
purified arabinogalactan
arabinogalactan
Prior art date
Application number
ZA200701311A
Other languages
English (en)
Inventor
Arora Sudershan Kumar
Srivastava Vandita
Walunj Sameer Shankar
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of ZA200701311B publication Critical patent/ZA200701311B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
ZA200701311A 2004-09-01 2007-02-14 A purified arabinogalactan-protein (AGP) composition ZA200701311B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/931,814 US7601368B2 (en) 2004-09-01 2004-09-01 Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders

Publications (1)

Publication Number Publication Date
ZA200701311B true ZA200701311B (en) 2009-08-26

Family

ID=35943518

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701311A ZA200701311B (en) 2004-09-01 2007-02-14 A purified arabinogalactan-protein (AGP) composition

Country Status (19)

Country Link
US (4) US7601368B2 (xx)
EP (1) EP1789439B1 (xx)
JP (1) JP2008511613A (xx)
KR (1) KR20070059062A (xx)
CN (1) CN101044161A (xx)
AP (1) AP2007003929A0 (xx)
AT (1) ATE452142T1 (xx)
AU (1) AU2005278780A1 (xx)
BR (1) BRPI0514347A (xx)
CA (1) CA2577134A1 (xx)
DE (1) DE602005018375D1 (xx)
EA (1) EA012208B1 (xx)
IL (1) IL181230A0 (xx)
MX (1) MX2007002428A (xx)
NO (1) NO20071120L (xx)
TN (1) TNSN07079A1 (xx)
UA (1) UA86986C2 (xx)
WO (1) WO2006025068A1 (xx)
ZA (1) ZA200701311B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399993T3 (es) 2007-03-02 2013-04-04 Protectimmun Gmbh Composición farmacéutica para la protección frente a alergias y enfermedades inflamatorias
FR2938192B1 (fr) 2008-11-07 2012-08-24 Expanscience Lab Nouvel actif anti-vergetures et compositions le comprenant
WO2010020379A1 (en) * 2008-08-16 2010-02-25 Protectimmun Gmbh Composition for prevention and treatment of allergic and/or inflammatory diseases
AU2011249145B2 (en) 2010-05-05 2013-05-23 Comvita New Zealand Limited Immunostimulatory compositions and methods of use thereof
FR2975004B1 (fr) * 2011-05-13 2013-06-28 Expanscience Lab Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
ITMI20112216A1 (it) 2011-12-05 2013-06-06 Fond Salvatore Maugeri Clinic A Del Lavoro E Composizione comprendente un estratto di chelidonium majus e copaiba e il suo impiego per il trattamento di disfunzioni cutanee
WO2014190398A1 (en) * 2013-05-31 2014-12-04 The University Of Melbourne Inhibition of amyloid fibril formation
US11179407B2 (en) 2015-12-01 2021-11-23 Forschungszentrum Borstel Leibniz-Zentrum Für Medizin Und Biowissenshaften Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
EP3176175B1 (en) 2015-12-01 2020-07-01 Ruhr-Universität Bochum Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
US10973858B2 (en) 2016-02-12 2021-04-13 Laimu Corporation Nerve growth promoter and method for producing same, internal preparation, medium additive, cell dilution additive, medium, cell dilution, antioxidant and method for producing same, external preparation, and wound treatment agent and method for producing same
JP6230638B2 (ja) * 2016-02-12 2017-11-15 株式会社らいむ 神経伸長促進剤、内服剤、培地用添加剤、細胞希釈液用添加剤、培地および細胞希釈液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818533A (en) * 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
US5494671A (en) * 1990-08-27 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
JP3177642B2 (ja) * 1991-09-10 2001-06-18 ライオン株式会社 抗男性ホルモン剤
WO2001000682A1 (en) 1999-06-30 2001-01-04 Pharmagenesis, Inc. Hematopoietic arabinogalactan composition
EP1467745A2 (en) * 2002-01-10 2004-10-20 Lupin Limited Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders

Also Published As

Publication number Publication date
NO20071120L (no) 2007-05-14
JP2008511613A (ja) 2008-04-17
AU2005278780A1 (en) 2006-03-09
EP1789439A1 (en) 2007-05-30
AP2007003929A0 (en) 2007-02-28
US20090270330A1 (en) 2009-10-29
BRPI0514347A (pt) 2008-06-10
CN101044161A (zh) 2007-09-26
WO2006025068A8 (en) 2006-04-20
US20060045930A1 (en) 2006-03-02
MX2007002428A (es) 2007-05-11
US20100330650A1 (en) 2010-12-30
US7601368B2 (en) 2009-10-13
EA012208B1 (ru) 2009-08-28
CA2577134A1 (en) 2006-03-09
EA200700532A1 (ru) 2007-08-31
KR20070059062A (ko) 2007-06-11
TNSN07079A1 (en) 2008-06-02
US20090264341A1 (en) 2009-10-22
DE602005018375D1 (de) 2010-01-28
ATE452142T1 (de) 2010-01-15
UA86986C2 (ru) 2009-06-10
WO2006025068A1 (en) 2006-03-09
EP1789439B1 (en) 2009-12-16
IL181230A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
ZA200701311B (en) A purified arabinogalactan-protein (AGP) composition
IL229521A0 (en) A new preparation
TWI340128B (en) A glass composition
EP1752496A4 (en) CURABLE COMPOSITION
EP1818368A4 (en) HARDENING COMPOSITION
EP1816168A4 (en) CURABLE COMPOSITION
IL185901A0 (en) Novel composition
EP1832626A4 (en) HARDENING COMPOSITION
EP1923431A4 (en) HARDENING COMPOSITION
EP1967540A4 (en) CURABLE COMPOSITION
PL1913075T3 (pl) Mieszanki kauczukowe zawierające ulepszone środki klejące
EP1939257A4 (en) HARDENING COMPOSITION
EP1882713A4 (en) HARDENING COMPOSITION
EP1754754A4 (en) CURABLE COMPOSITION
EP1731549A4 (en) VULCANIZABLE COMPOSITION
EP1715002A4 (en) CURABLE COMPOSITION
EP1930376A4 (en) POLYMERIZABLE COMPOSITION
EP1731573A4 (en) VULCANIZABLE COMPOSITION
EP1666536A4 (en) CURABLE COMPOSITION
EP1810994A4 (en) CURABLE PREPARATION
EP1970411A4 (en) HARDENING COMPOSITION
EP1810995A4 (en) CURABLE PREPARATION
EP1810996A4 (en) CURABLE PREPARATION
GB0525592D0 (en) A composition
GB0427403D0 (en) Novel compounds I